| Home > Zentren > Zentrum für Innere Medizin > I. Medizinische Klinik und Poliklinik > Publikationen > 2004
Atanackovic D., Block A., de Weerth A., Faltz C., Hossfeld D. K., Hegewisch-Becker S:
Characterization of Effusion-Infiltrating T Cells: Benign versus Malignant Effusions.
Clinical Cancer Research 2004; 10: 2600-2608
http://www.ncbi.nlm.nih.gov/sites/entrez15102661
Bayer EM, Schramm C, Kanzler S, Lohse AW:
Autoimmune liver disease: diagnosis and therapy.
Z Gastroenterol 2004; 42:19-30
http://www.ncbi.nlm.nih.gov/sites/entrez/14997400
Becker C, Fantini MC, Schramm C, Lehr HA, Burg J, Strand D, Schmidt J, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF:
TGF-beta suppresses tumor progression in colitis associated colon cancer by inhibition of IL-6 trans-signaling.
Immunity 2004; 21: 491-501
http://www.ncbi.nlm.nih.gov/sites/entrez/15485627
Beinborn M, Ren Y, Bläker M, Chen C, Kopin AS:
Ligand Function at Constitutively Active Receptor Mutants Is Affected by Two Distinct Yet Interacting Mechanisms.
Molecular Pharmacology 2004; 65: 753-760
http://www.ncbi.nlm.nih.gov/sites/entrez/14978254
Berg T., Sarrazin C., Hinrichsen H., Buggisch P., Gerlach T., Zachoval R. Zeuzem S.
Does Non-invasive Staging of Fibrosis Challenge Liver Biopsy as a Gold Standard in Chronic Hepatitis C?
Hepatology, 2004, 39(5): 1456-1457
http://www.ncbi.nlm.nih.gov/sites/entrez/15122779
Bläker M, Arrenberg P, Stange I, Schulz M, Burghardt S, Michaelis H, Pace A, Greten H, von Schrenck T, de Weerth A:
The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT.
Regulatory Peptides 2004; 118: 111-117
http://www.ncbi.nlm.nih.gov/sites/entrez/14759564
Bläker M, Schmitz M, Gocht A, Burghardt S, Schulz M, Broering DC, Pace A, Greten H, de Weerth A:
Differential Expression of Somatostatin Receptor Subtypes in Hepatocellular Carcinomas.
J Hepatol 2004; 41: 112-118
http://www.ncbi.nlm.nih.gov/sites/entrez/15246216
Broering DC, Wilms C, Bok P, Fischer L, Mueller L, Hillert C, Lenk C, Kim JS, Sterneck M, Schulz KH, Krupski G, Nierhaus A, Ameis D, Burdelski M, Rogiers X.:
Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases
Annals of Surgery 2004; 240(6), 1013-1024
http://www.ncbi.nlm.nih.gov/sites/entrez/15570207
De Wit M, Raabe A, Seegers B, Buchert R, Beck-Bornholdt HP, Alberti W, Hossfeld DK:
Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
Int J Radiat Biol 2004; 80: 529-539
http://www.ncbi.nlm.nih.gov/sites/entrez/15360091
Denzer U, Hoffmann S, Helmreich-Becker I, Kauczor HU, Thelen M, Kanzler S, Galle PR, Lohse AW:
Minilaparoscopy in the diagnosis of peritoneal tumor spread: prospective controlled comparison tomography.
Surg Endosc 2004; 18: 1067-70
http://www.ncbi.nlm.nih.gov/sites/entrez/15156385
Finotto S, Siebler J, Hausding M, Schipp M, Wirtz S, Klein S, Protschka M., Doganici A, Lehr H, Trautwein C, Khosravi-Fahr R, Strand D, Lohse AW, Galle PR; Blessing M, Neurath MF:
Severe hepatic injury in interleukin 18 (IL-18) transgenic mice; a key role for IL-18 in regulation in vivo.
Gut 2004; 53: 392-400
http://www.ncbi.nlm.nih.gov/sites/entrez/14960523
Gibril F, Schumann M, Pace A, Jensen RT:
Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
Medicine (Baltimore). 2004; 83: 43-83.
http://www.ncbi.nlm.nih.gov/sites/entrez/14747767
Gupta S, Inada M, Joseph B, Kumaran V, Benten D:
Emerging insights into liver-directed cell therapy for genetic and acquired disorders.
Transpl Immunol 2004; 12: 289-302
http://www.ncbi.nlm.nih.gov/sites/entrez/15157922
Herkel J, Kam N, Mimran A, Erez N, Heifetz A, Eisenstein M, Rotter V, Cohen IR.
Monoclonal antibody to a DNA-binding domain of p53 mimics charge structure of DNA: Anti-idiotypes to the anti-p53 antibody are anti-DNA.
Eur J Immunol 2004; 34:3623-3632
http://www.ncbi.nlm.nih.gov/sites/entrez/15495163
Huber S, Schramm C, Lehr HA, Mann A, Schmidt S, Becker C, Protschka M, Galle PR, Neurath MF, Blessing M:
TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T-cells.
J Immunol 2004; 173: 6526-6531
http://www.ncbi.nlm.nih.gov/sites/entrez/15557141
Joseph B, Berishvili E, Benten D, Kumaran V, Liponava E, Bhargava K, Palestro C, Kakabadze Z, Gupta S:
Isolated small intestinal segments support auxiliary livers with maintenance of hepatic functions.
Nat Med 2004; 10: 749-53
http://www.ncbi.nlm.nih.gov/sites/entrez/15170210
Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, Maccagno G, Barreiros AP, Lüth S, Schimanski C, Schuchmann M, Schwarting A, Neurath M, Otto G, Galle PR, Lohse AW:
Control of organ transplant-asociated graft-versus-host disease by activated host lymphocyte infusion.
Transplantation 2004; 78: 1774-9
http://www.ncbi.nlm.nih.gov/sites/entrez/15614150
Lohse AW, Blum HF:
The German Association for the Study of the Liver (GASL) in the German Journal of Gastroenterology.
Z Gastroenterol 2004; 42: 7-8
http://www.ncbi.nlm.nih.gov/sites/entrez/14997397
Mascheretti S., Hinrichsen H., Ross S., Buggisch P., Hampe I., Foelsch U., Schreiber S.:
Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients.
Clin. and Exp. Immunology, 2004, 136(2): 328-333
http://www.ncbi.nlm.nih.gov/sites/entrez/15086398
Moench C, Uhrig A, Lohse AW, Otto G:
CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions for transplantation.
Liver Transpl 2004; 10: 434-9
http://www.ncbi.nlm.nih.gov/sites/entrez/15004773
Möhler M, Höhler T, Denzer U, Galle PR, Heike M:
Neue Therapieoptionen des fortgeschrittenen oder metastasierten Magenkarzinoms.
Zeitschrift für Verdauungskrankheiten 2004; 4:192-200
Mosler P, Mergener K, Denzer U, Kiesslich R, Galle PR, Kanzler S:
Gastrointestinal endoscopy: Current practice in mangement of patients taking anticoagulants and / or antiplatelet agents. A nationwide survey in Germany.
Z Gastroenterol 2004; 42: 1289-93
http://www.ncbi.nlm.nih.gov/sites/entrez/15558438
Otto G, Romaneechsen B, Bittinger F, Moench C, Thelen M, Hadian A, Lohse AW:
Preoperative imaging of hilar cholangiocarcinoma; surgical evaluation of standard practises.
Z Gastroenterol 2004; 42: 9-14
http://www.ncbi.nlm.nih.gov/sites/entrez/14997398
Peters M. G., Hann Hw H., Martin P., Heathcote E. J., Buggisch P., Rubin R., Bourliere M.
Kowdley K., Trepo C., Gray Df. D., Sullivan M., Kleber K., Ebrahimi R., Xiong S. Brosgart C. L.
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
Gastroenterology, 2004, 126(1): 91-101
http://www.ncbi.nlm.nih.gov/sites/entrez/14699491
Pollmann A., Kabisch H., Block A., Müller J., Hellwinkel O.:
Limited specificity of promoter constructs for gene therapy in Osteosarcoma.
Int. J Mol Med 2004; 14: 737-742
http://www.ncbi.nlm.nih.gov/sites/entrez/15375610
Romaneehsen B, Otto G, Lohse AW, Bittinger F., Herber S, Oberholzer K, Pitton MB, Thelen M:
Diagnostic Imaging of Hilar Cholangiocarcinoma: Preoperative Evaluation of ERC, MRC and PTC in comparison with Histopathology.
Röfo 2004, 176:1750-8
http://www.ncbi.nlm.nih.gov/sites/entrez/15573285
Schimanski CC, Burg J, Möhler M, Höhler T, Kanzler S, Otto G, Galle PR, Lohse AW:
Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure.
J Hepatol 2004; 41: 67-74
http://www.ncbi.nlm.nih.gov/sites/entrez/15246210
Schramm C, Huber S, Protschka M, Czochra P, Burg J, Schmitt E, Lohse AW, Galle PR, Blessing M:
TGFbeta regulates the CD4+CD25+T-cell pool and the expression of Foxp3 in vivo.
Int Immunol 2004; 16: 1241-9
http://www.ncbi.nlm.nih.gov/sites/entrez/15249539
Schramm C, Kriegsmann J, Protschka M, Hansen T, Huber S, Schmitt E, Galle PR, Blessing M:
Susceptibility to collagen induced arthritis is modulated by TGFbeta responsiveness of T-cells.
Arthritis Res Ther 2004; 6: R114-R119
http://www.ncbi.nlm.nih.gov/sites/entrez/15059274
Schuchmann M, Hermann F, Herkel J, van der Zee R, Galle PR, Lohse AW:
HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cell.
Immunol Lett 2004; 93: 199-204
http://www.ncbi.nlm.nih.gov/sites/entrez/15158617
Shirahashi H, Wu J, Yamamoto N, Catana A, Wege H, Wager B, et al:
Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage.
Cell Transplant 2004; 13: 197-211
http://www.ncbi.nlm.nih.gov/sites/entrez/15191158
Werle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney W, Xiong S, Brosgart C.L., Shen C.C., Gibbs C, Gibbs C, Zoulim F.
New Insights of cccDNA persistence during the natural history of Chronic Hepatitis B and Adefovir Dipivoxil Therapy.
Gastroenterology 2004;126:1750-58
http://www.ncbi.nlm.nih.gov/sites/entrez/15188170
Zöllner B, Petersen J, Schäfer P, Schröter M, Laufs R, Sterneck M, Feucht HH:
Viral features of lamivudine resistant hepatitis B genotypes A and D.
Hepatology 2004; 39: 42-50
http://www.ncbi.nlm.nih.gov/sites/entrez/14752821
